Acumen Pharmaceuticals, Inc. (ABOS)
1.78
+0.09
(+5.33%)
USD |
NASDAQ |
Oct 19, 16:00
1.78
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Price : 1.78 for Oct. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.67 | 1.715 | 1.62 | 1.69 | 449342.0 |
| Oct 15, 2026 | 1.71 | 1.755 | 1.66 | 1.67 | 602707.0 |
| Oct 14, 2026 | 1.81 | 1.87 | 1.71 | 1.745 | 620856.0 |
| Oct 13, 2026 | 2.00 | 2.00 | 1.81 | 1.815 | 646336.0 |
| Oct 12, 2026 | 2.14 | 2.14 | 2.00 | 2.02 | 291649.0 |
| Oct 09, 2026 | 2.12 | 2.17 | 2.081 | 2.14 | 357544.0 |
| Oct 08, 2026 | 2.09 | 2.135 | 2.020 | 2.10 | 505169.0 |
| Oct 07, 2026 | 2.02 | 2.17 | 2.00 | 2.10 | 623092.0 |
| Oct 06, 2026 | 2.13 | 2.14 | 2.00 | 2.03 | 562869.0 |
| Oct 05, 2026 | 2.04 | 2.16 | 2.015 | 2.13 | 713980.0 |
| Oct 02, 2026 | 2.10 | 2.10 | 2.015 | 2.04 | 580520.0 |
| Oct 01, 2026 | 2.22 | 2.29 | 2.07 | 2.07 | 833409.0 |
| Sep 30, 2026 | 2.25 | 2.45 | 2.10 | 2.22 | 1.483M |
| Sep 29, 2026 | 2.30 | 2.42 | 2.22 | 2.245 | 1.087M |
| Sep 28, 2026 | 2.22 | 2.375 | 2.19 | 2.30 | 856379.0 |
| Sep 25, 2026 | 2.25 | 2.295 | 2.22 | 2.24 | 235303.0 |
| Sep 24, 2026 | 2.30 | 2.34 | 2.22 | 2.235 | 265853.0 |
| Sep 23, 2026 | 2.63 | 2.63 | 2.30 | 2.305 | 471447.0 |
| Sep 22, 2026 | 2.61 | 2.705 | 2.60 | 2.65 | 568359.0 |
| Sep 21, 2026 | 2.63 | 2.645 | 2.555 | 2.59 | 395179.0 |
| Sep 18, 2026 | 2.55 | 2.67 | 2.515 | 2.65 | 890160.0 |
| Sep 17, 2026 | 2.69 | 2.760 | 2.535 | 2.57 | 490021.0 |
| Sep 16, 2026 | 2.92 | 2.95 | 2.590 | 2.61 | 369337.0 |
| Sep 15, 2026 | 2.77 | 2.90 | 2.69 | 2.89 | 359312.0 |
| Sep 14, 2026 | 2.91 | 3.015 | 2.78 | 2.79 | 394216.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 233.52 |
| ACADIA Pharmaceuticals, Inc. | 19.81 |
| Alnylam Pharmaceuticals, Inc. | 233.37 |
| Anika Therapeutics, Inc. | 20.24 |
| Savara, Inc. | 4.635 |
Price Related Metrics
| Price to Book Value | 2.248 |
| Earnings Yield | -91.71% |
| Market Cap | 128.72M |